HomeTable of contents
Table of contents
October 2024 - Volume 2 - 4
Editorial
22 December 2024•
New therapeutic target for alcohol-associated hepatitis (AH): AH-associated IL-8+ neutrophilsYukun Guan, Dechun Feng, Luca Maccioni, Yang Wang, Bin Gao
Review
31 December 2024•
Essential roles of the unfolded protein response in intestinal physiologyClaudio Hetz, Juan Francisco Silva-Agüero, Lisa M Ellerby
23 December 2024•
Faecal microbiota transplantation for eradicating Helicobacter pylori infection: clinical practice and theoretical postulationZhi-Ning Ye, Guy D Eslick, Shao-Gang Huang, Xing-Xiang He
10 December 2024•
Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver diseaseHui Gao, Yanchao Jiang, Ge Zeng, Nazmul Huda, Themis Thoudam, Zhihong Yang, Suthat Liangpunsakul, Jing Ma
18 November 2024•
Mechanistic role of long non-coding RNAs in the pathogenesis of metabolic dysfunction-associated steatotic liver disease and fibrosisHenry Wade, Kaichao Pan, Bingrui Zhang, Wenhua Zheng, Qiaozhu Su
4 October 2024•
Drug-target Mendelian randomisation applied to metabolic dysfunction-associated steatotic liver disease: opportunities and challengesShan Luo, Ming-Hua Zheng, Vincent Wai-Sun Wong, Shiu Lun Au Yeung
Original research
11 November 2024•
Endocrine pathology in young rabbits with cystic fibrosisXiubin Liang, Xia Hou, Y Eugene Chen, Jian-Ping Jin, Kezhong Zhang, Jie Xu
18 October 2024•
Early clinical predictors of infected pancreatic necrosis: a multicentre cohort studyKai Song, Wenhua He, Zuoyan Wu, Jie Meng, Wei Tian, Shicheng Zheng, Dong Mu, Ruifeng Wang, Hongda Chen, Yin Zhu, Dong Wu